Evidence map›Paper›PMID 41537276›Full record

ArticleInternational journal of surgery (London, England)2026

Trends in the global, regional, and national burden of pancreatitis among children and adolescents based on the GBD 2021.

Mengran Yu, Weiguo Dong

Abstract read
In one paragraph

Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mengran YuDepartment of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.ORCID 0000-0003-3408-8437
Weiguo Dong

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncreasing pancreatitis incidence among children and adolescents has emerged as a public health challenge. Using data from the Global Burden of Disease (GBD) Study 2021, this study aims to analyze the global, regional, and national burden of pancreatitis in pediatric populations from 1990 to 2021.

methodsUsing GBD 2021 data, we analyzed numbers and age-standardized rates of incidence, mortality, and disability-adjusted life years (DALYs) in populations aged 0-19 years at global, regional, and national levels, stratified by sex, age, and sociodemographic index (SDI). Furthermore, decomposition analysis, frontier analysis, and Bayesian age-period-cohort (BAPC) prediction were performed.

resultsGlobally, the incidence burden of pancreatitis in children and adolescents increased from 1990 to 2021, with the number of cases rising from 156 383.64 to 194 636.05 and the age-standardized incidence rate (ASIR) increasing from 6.91 to 7.18 per 100 000. Conversely, mortality and DALY burdens declined, with deaths decreasing from 1309.23 to 1120.09 and the age-standardized mortality rate (ASMR) dropping from 0.06 to 0.04 per 100 000. DALY cases decreased from 113 917.02 to 100 041.07 and the age-standardized DALY rate (ASDR) dropped from 4.99 to 3.65 per 100 000. Adolescents aged 15-19 years demonstrated the highest disease burden. Females exhibited higher incidence, while males demonstrated significantly higher mortality and DALYs. Predictions indicate sustained reductions in ASIR, ASMR, and ASDR until 2040.

conclusionDespite declining mortality and DALY burdens, pancreatitis incidence among children and adolescents has increased, underscoring its significance as a global health threat. Geographic, age, gender, and SDI disparities persist.

Indexed as

children and adolescentsdisease burdenpancreatitis

Identifiers

PMID41537276
PMCPMC13105712

What Socratic holds

Textmetadata
LicenceCC BY-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.